Skip to content
  1. Home/
  2. Media Center/
  3. Press releases /
  4. Financial

Financial

Johnson & Johnson Reports 2016 Third-Quarter Results

Sales of $17.8 Billion Increased 4.2% versus 2015 Third Quarter Third-Quarter EPS was $1.53, Adjusted 2016 Third-Quarter EPS of $1.68 Increased 12.8%*

Johnson & Johnson to Participate in the 2016 Wells Fargo 11th Annual Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the 2016 Wells Fargo 11th Annual Healthcare Conference on Thursday, Sept. 8, at The Westin Boston Waterfront in Boston, MA.

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 19th, to review second-quarter results.

Johnson & Johnson Recognized as Winner of the GBCHealth 2016 Women & Girls Business Action on Health Award

Award honors business leadership in improving the health and well-being of women and girls

Johnson & Johnson Announces Revival of Kilmer Conference — The Premier Global Forum for Sterility Assurance

Company to Donate Prior Kilmer Conference Proceedings on Sterility Assurance to Association for the Advancement of Medical Instrumentation